VANACOF is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Gm Pharmaceuticals, Inc. The primary component is Chlophedianol Hydrochloride; Dexchlorpheniramine Maleate; Pseudoephedrine Hydrochloride.
Product ID | 58809-999_6e48017a-a48a-4b1a-8e4b-5d4003560de5 |
NDC | 58809-999 |
Product Type | Human Otc Drug |
Proprietary Name | VANACOF |
Generic Name | Chlophedianol Hydrochloride, Dexchlorpheniramine Maleate, And Pseudoephedrine Hydrochloride |
Dosage Form | Liquid |
Route of Administration | ORAL |
Marketing Start Date | 2008-04-22 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | GM Pharmaceuticals, INC |
Substance Name | CHLOPHEDIANOL HYDROCHLORIDE; DEXCHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE |
Active Ingredient Strength | 13 mg/5mL; mg/5mL; mg/5mL |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2008-04-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2008-04-22 |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 2008-04-22 |
Ingredient | Strength |
---|---|
CHLOPHEDIANOL HYDROCHLORIDE | 12.5 mg/5mL |
SPL SET ID: | cf3886ab-62b3-497a-a587-18cbfbaf3634 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
58809-999 | VANACOF | Chlophedianol Hydrochloride, Dexchlorpheniramine Maleate, and Pseudoephedrine Hydrochloride |
69367-183 | chlophedianol hydrochloride, dexchlorpheniramine maleate, and pseudoephedrine hydrochloride | chlophedianol hydrochloride, dexchlorpheniramine maleate, and pseudoephedrine hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VANACOF 77310107 3565619 Live/Registered |
GM Pharmaceuticals, Inc. 2007-10-22 |